unknown
Stage
1
Investors
About
Curapath is a global CDMO specializing in GMP manufacturing of polymer and lipid-based drug delivery systems, providing end-to-end services for preclinical, clinical, and commercial stages with a focus on non-viral gene delivery via nanoparticles.
Explore Curapath's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.